Matches in Wikidata for { <http://www.wikidata.org/entity/Q66069683> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q66069683 description "clinical trial" @default.
- Q66069683 description "ensayu clínicu" @default.
- Q66069683 description "klinisch onderzoek" @default.
- Q66069683 description "клінічне випробування" @default.
- Q66069683 name "A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered)." @default.
- Q66069683 name "A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine" @default.
- Q66069683 type Item @default.
- Q66069683 label "A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered)." @default.
- Q66069683 label "A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine" @default.
- Q66069683 prefLabel "A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered)." @default.
- Q66069683 prefLabel "A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine" @default.
- Q66069683 P1132 Q66069683-081FE2DC-66C2-4180-99EB-89B5E56327B2 @default.
- Q66069683 P1476 Q66069683-DC14D68E-5798-40C9-86C0-ACB06201774C @default.
- Q66069683 P17 Q66069683-C6E84783-420B-4798-B730-544E9DA11B5A @default.
- Q66069683 P2283 Q66069683-8A521041-6D99-42E7-A10E-1790CBDAA35A @default.
- Q66069683 P2899 Q66069683-FC72E90D-25B7-4E4B-AE44-2377D25E6EB4 @default.
- Q66069683 P3098 Q66069683-26388C00-BC34-4443-B79A-C00BEBEA7683 @default.
- Q66069683 P31 Q66069683-42FDBF5E-0933-4E57-8995-8ED4E3D512A1 @default.
- Q66069683 P366 Q66069683-0559A7B6-37BE-4D34-BDB4-94B5673F27AF @default.
- Q66069683 P4135 Q66069683-87F52C5C-1A5C-452D-9141-96278A29AB58 @default.
- Q66069683 P580 Q66069683-ACB4352F-6A65-4930-890E-5195E300DC5B @default.
- Q66069683 P582 Q66069683-1DB71E93-6142-465B-AA1E-EC0FE34B18F9 @default.
- Q66069683 P6099 Q66069683-FDEA0F30-6247-40FD-801E-2A3C175598B2 @default.
- Q66069683 P6153 Q66069683-3BBA675F-0DC6-4B2B-9731-F2DA4EF57FAB @default.
- Q66069683 P8363 Q66069683-E4D3FB38-100D-47BA-BD4B-0FEDA18940E3 @default.
- Q66069683 P859 Q66069683-CC68A6C8-B945-499E-83F9-C722C0202A29 @default.
- Q66069683 P1132 "+229" @default.
- Q66069683 P1476 "A PHASE IIIB, OPEN STUDY TO EVALUATE THE IMMUNOGENICITY, REACTOGENICITY AND SAFETY OF A BOOSTER DOSE OF MENACWY-TT VACCINE ADMINISTERED 10 YEARS AFTER HEALTHY SUBJECTS AGED 11-17 YEARS RECEIVED EITHER MENACWY-TT VACCINE (NIMENRIX(REGISTERED)) OR MENCEVAX ACWY(REGISTERED)." @default.
- Q66069683 P17 Q928 @default.
- Q66069683 P2283 Q73214260 @default.
- Q66069683 P2899 "+20" @default.
- Q66069683 P3098 "NCT03189745" @default.
- Q66069683 P31 Q30612 @default.
- Q66069683 P366 Q73214260 @default.
- Q66069683 P4135 "+28" @default.
- Q66069683 P580 "2017-08-01T00:00:00Z" @default.
- Q66069683 P582 "2018-04-11T00:00:00Z" @default.
- Q66069683 P6099 Q42824827 @default.
- Q66069683 P6153 Q7315099 @default.
- Q66069683 P8363 Q78089383 @default.
- Q66069683 P859 Q206921 @default.